About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05585333

Photobiomodulation Therapy Treatment on Facial Paralysis

Objective: Facial paralysis can be caused by a variety of etiological factors, complete palsy continues for two months, the chance of full recovery is reduced to zero. The aim of this study was to eva...

Lead sponsor: Beijing Tongren Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Beijing Tongren Hospital

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\- (1) adults over 18 years of age and under 65 years of age. (2) had not received medicine, such as prednisolone. (3) had history of Bell's palsy, Ramsay Hunt syndrome, traumatic facial paralysis and history of otological surgery.
•(4) Disease duration longer than two months.

Exclusion Criteria

•\- (1) Complete facial paralysis (HB 6). (2) Greater than 90% denervation on ENoG. (3) No voluntary EMG activity. (4) No latency of early (R1) and late (R2, R2') components in blink reflex. (5) Serious mental illness or social problems, and neurological disorders. (6) Systemic disease, such as severe diabetes, malignant tumors and other serious consumptive diseases.
•(7) Planning for pregnancy, in pregnancy or lactation.

Related studies

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

NCT06335719 · Facial Paralysis

The Relationship Between Idiopathic Acute Peripheral Facial Paralysis and Homocysteine Level in Adult Patients

NCT06742580 · Facial Paralysis, Peripheral, Bell Palsy

Functional Recovery From Facial Paralysis

NCT06532903 · Peripheral Facial Paralysis, Facial Palsy, and more

Clinical Study on the End Time of Acupuncture and Moxibustion Therapy for Peripheral Facial Paralysis

NCT06393231 · Peripheral Facial Paralysis

COMPLETEDPhase 3

Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

NCT05945615 · Blepharoptosis, Synkinesis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 9, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment54

Start dateJan 2021

Last updatedNov 9, 2022

Condition

Facial Paralysis

Locations shown

Beijing TongRen Hospital, Capital Medical University

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 9, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions